Effects of atomoxetine on cognitive function and cigarette smoking in schizophrenia

Schizophrenia Research

Volumn 107, Issue 2-3, 2009, Pages 332-333

  Sacco, Kristi A ^a   Creeden, Cerissa ^a   Reutenauer, Erin L ^a   Vessicchio, Jennifer C ^a   Weinberger, Andrea H ^a   George, Tony P ^a,b  

^a Department of Psychiatry   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ATOMOXETINE; CARBON MONOXIDE; DOPAMINE;

ATTENTION; BRAIN FUNCTION; CIGARETTE SMOKING; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; DRUG EFFECT; HUMAN; LEARNING; LETTER; MEMORY; MENTAL DISEASE; MOTOR PERFORMANCE; NEUROPSYCHOLOGICAL TEST; PREFRONTAL CORTEX; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA; SYMPTOM;

ADRENERGIC UPTAKE INHIBITORS; COGNITION DISORDERS; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; NOREPINEPHRINE; PREFRONTAL CORTEX; PROPYLAMINES; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SMOKING; SMOKING CESSATION;

EID: 58249107927     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2008.09.026     Document Type: Letter

References (6)

1. Bymaster F.P., Katner J.S., Nelson D.L., Hemrick-Luecke S.K., Threlkeld P.G., Heiligenstein J.H., Morin S.M., Gehlert D.R., and Perry K.W. Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder. Neuropsychopharmacology. 27 5 (2002) 699-711
2. Depatie L., Driscoll G.A., Holahan A.-L.V., Atkinson V., Thavundayil J.X., Ying Kin N.N., and Samarthji L. Nicotine and behavioral markers of risk for schizophrenia: a double-blind, placebo-controlled, cross-over study. Neuropsychopharmacology 27 (2002) 1056-1070
3. Friedman J.I., Carpenter D., Lu J., Fan J., Tang C.Y., White L., Parella M., Bowler S., Elbaz Z., Flanagan L., and Harvey P.D. A pilot study of adjunctive atomoxetine treatment to second-generation antipsychotics for cognitive impairment in schizophrenia. Journal of Clinical Psychopharmacology 28 1 (2008) 59-63
4. George T.P., Vessicchio J.C., Termine A., Sahady D.M., Head C.A., and Pepper W.T. Effects of smoking abstinence on visuospatial working memory function in schizophrenia. Neuropsychopharmacology 26 (2002) 75-85
5. Knable M.B., and Weinberger D.R. Dopamine, the prefrontal cortex and schizophrenia. J. Psychopharmacol. 11 2 (1997) 123-131
6. Sacco K.A., Termine A., Seyal A.A., Dudas M.M., Vessicchio J.C., Krishnan-Sarin S., Jatlow P.I., Wexler B.E., and George T.P. Effects of cigarette smoking function on spatial working memory and attentional function in schizophrenia: involvement of nicotinic receptor mechanisms. Arch. Gen. Psychiatry 62 (2005) 649-659